C12N

Technology



back to "C12N" profile

More Results

Showing 1 to 20 of 69551 results

Patent/Pub #TitleFiling DateIssue/Publication DatePatent Owner
RE49936 Beta-hexosyl-transferases and uses thereofDec 18, 20Apr 23, 24North Carolina State University
RE49736 Pegylated L-asparaginaseMar 18, 20Nov 28, 23Jazz Pharmaceuticals II SAS
RE49708 Nucleic acid molecules encoding indoleamine 2,3-dioxygenase-2Jan 08, 21Oct 24, 23Lankenau Institute for Medical Research
RE49583 Inducible expression systemsFeb 03, 21Jul 18, 23TET Systems GmbH & Co. KG
RE49431 RNA interference agents for GST-PI gene modulationAug 11, 20Feb 28, 23Nitto Denko Corporation
RE49423 DNA plasmids with improved expressionDec 04, 20Feb 21, 23Nature Technology Corporation
RE49347 Mammalian expression vectorAug 23, 18Dec 27, 22Novartis AG
RE49311 RTI545 compositions and methods of use for benefiting plant growth and controlling plant pestsJan 22, 20Nov 29, 22FMC Corporation
RE49293 Cell culture methods and devices utilizing gas permeable materialsJun 12, 18Nov 15, 22Wilson Wolf Manufacturing Corporation
RE49294 DNA vector production systemMar 05, 20Nov 15, 22Mediphage Bioceuticals, Inc.
RE49280 TGFbeta type II-type III receptor fusionsApr 04, 19Nov 08, 22501 Board of Regents The University of Texas System
RE49281 Wnt pathway stimulation in reprogramming somatic cells with nuclear reprogramming factorsDec 13, 19Nov 08, 22Whitehead Institute for Biomedical Research
RE49233 Ionizable cationic lipid for RNA deliveryMar 12, 19Oct 04, 22Arcturus Therapeutics, Inc.
RE49229 Methods and compositions for treating malignant tumors associated with KRAS mutationFeb 28, 20Oct 04, 22Nitto Denko Corporation
RE49121 Genetically modified mouse with an inducible ACVR1 gene with a mutant R206H exon 5 that has ectopic bone formationNov 13, 18Jul 05, 22Regeneron Pharmaceuticals, Inc.
RE48960 Antisense oligonucleotides for inducing exon skipping and methods of use thereofDec 19, 19Mar 08, 22THE UNIVERSITY OF WESTERN AUSTRALIA
RE48908 DNA vector production systemOct 30, 19Feb 01, 22Mediphage Bioceuticals, Inc.
RE48887 RNA interference compositions and methods for malignant tumorsSep 19, 19Jan 11, 22Nitto Denko Corporation
RE48863 toxin and methods thereofApr 18, 19Dec 28, 21Wyeth LLC
RE48862 toxin and methods thereofApr 18, 19Dec 28, 21Wyeth LLC

Showing 1 to 20 of 69551 results